Get the latest Aberdeen Latin American Equity R (ALREX) stock news and headlines to help you in your trading and investing decisions.

Loteprednol Etabonate Ophthalmic Suspension, 0.2% (RLD Alrex), had a market value of roughly $29.1 million, per IQVIA October 2023 data.

In Biofarma SA v OHIM , the European Court of First Instance has rejected an application to register ALREX as a Community trademark on the basis that it was confusingly similar to the earlier mark ...

This blog explains how to use trade alrex, walks you through the registration procedure, and outlines the fundamental characteristics of a successful trading bot. The Transformative Benefits of ...

The reference product, RLD Alrex, achieved an estimated annual sales figure of $29.1 million in the U.S. as of October 2023 (IQVIA MAT). Also read: Aurobindo Pharma arm receives USFDA approval for ...